Nelson CJ, Nandy N, Roth AJ: Chemotherapy and cognitive deficits: mechanisms, findings, and potential interventions. Palliative & supportive care. 2007, 5 (03): 273-280.
Article
Google Scholar
Biglia N, Bounous VE, Malabaila A, Palmisano D, Torta DM, D'Alonzo M, Sismondi P, Torta R: Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study. Eur J Cancer Care (Engl). 2012, 21 (4): 485-492. 10.1111/j.1365-2354.2011.01320.x. doi: 10.1111/j.1365-2354.2011.01320.x. Epub 2011 Dec 28
Article
CAS
Google Scholar
Dutta V: Chemotherapy, neurotoxicity, and cognitive changes in breast cancer. J Cancer Res Ther. 2011, 7 (3): 264-10.4103/0973-1482.87008.
Article
PubMed
Google Scholar
Wefel JS, Vardy J, Ahles T, Schagen SB: International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol. 2011, 12 (7): 703-708. 10.1016/S1470-2045(10)70294-1. doi: 10.1016/S1470-2045(10)70294-1. Epub 2011 Feb 25
Article
PubMed
Google Scholar
Wefel JS, Witgert ME, Meyers CA: Neuropsychological sequelae of non-central nervous system cancer and cancer therapy. Neuropsychol Review. 2008, 18 (2): 121-131. 10.1007/s11065-008-9058-x.
Article
Google Scholar
Batalo M, Nagaiah G, Abraham J: Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther. 2011, 11 (8): 1277-1282. 10.1586/era.11.112.
Article
CAS
PubMed
Google Scholar
Khasraw M, Posner JB: Neurological complications of systemic cancer. Lancet Neurol. 2010, 9 (12): 1214-1227. 10.1016/S1474-4422(10)70220-9.
Article
PubMed
Google Scholar
Hermelink K: Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer. 2011, 117 (5): 1103-1103.
Article
PubMed
Google Scholar
Wefel JS, Schagen SB: Chemotherapy-related cognitive dysfunction. Curr Neurol Neurosci Rep. 2012, 12 (3): 267-275. 10.1007/s11910-012-0264-9.
Article
CAS
PubMed
Google Scholar
Correa DD, Hess LM: Cognitive function and quality of life in ovarian cancer. Gynecol Oncol. 2012, 124 (3): 404-409. 10.1016/j.ygyno.2011.11.005.
Article
PubMed
Google Scholar
Castellino SM, Tooze JA, Flowers L, Hill DF, McMullen KP, Shaw EG, Parsons SK: Toxicity and efficacy of the acetylcholinesterase (AChe) inhibitor donepezil in childhood brain tumor survivors: a pilot study. Pediatr Blood Cancer. 2012, 59 (3): 540-547. 10.1002/pbc.24078. doi: 10.1002/pbc.24078. Epub 2012 Jan 11
Article
PubMed
PubMed Central
Google Scholar
Shaw EG, Rosdhal R, D’Agostino RB, Lovato J, Naughton MJ, Robbins ME, Rapp SR: Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol. 2006, 24 (9): 1415-1420. 10.1200/JCO.2005.03.3001.
Article
CAS
PubMed
Google Scholar
Mulhern RK, Khan RB, Kaplan S, Helton S, Christensen R, Bonner M, Brown R, Xiong X, Wu S, Gururangan S: Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer. J Clin Oncol. 2004, 22 (23): 4795-4803. 10.1200/JCO.2004.04.128.
Article
CAS
PubMed
Google Scholar
Conklin HM, Khan RB, Reddick WE, Helton S, Brown R, Howard SC, Bonner M, Christensen R, Wu S, Xiong X: Acute neurocognitive response to methylphenidate among survivors of childhood cancer: a randomized, double-blind, cross-over trial. J Pediatr Psychol. 2007, 32 (9): 1127-1139. 10.1093/jpepsy/jsm045.
Article
PubMed
Google Scholar
Daly BP, Brown RT: Scholarly literature review: management of neurocognitive late effects with stimulant medication. J Pediatr Psychol. 2007, 32 (9): 1111-1126. 10.1093/jpepsy/jsm012.
Article
PubMed
Google Scholar
Thompson SJ, Leigh L, Christensen R, Xiong X, Kun LE, Heideman RL, Reddick WE, Gajjar A, Merchant T, Pui CH: Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer. J Clin Oncol. 2001, 19 (6): 1802-1808.
CAS
PubMed
Google Scholar
Hermelink K, Untch M, Lux MP, Kreienberg R, Beck T, Bauerfeind I, Münzel K: Cognitive function during neoadjuvant chemotherapy for breast cancer. Cancer. 2007, 109 (9): 1905-1913. 10.1002/cncr.22610.
Article
CAS
PubMed
Google Scholar
Holmes D: Trying to unravel the mysteries of chemobrain. Lancet Neurol. 2013, 12 (6): 533-534. 10.1016/S1474-4422(13)70087-5. doi: 10.1016/S1474-4422(13)70087-5. Epub 2013 Apr 19
Article
PubMed
Google Scholar
Aluise CD, Sultana R, Tangpong J, Vore M, St Clair D, Moscow JA, Butterfield DA: Chemo brain (chemo fog) as a potential side effect of doxorubicin administration: role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction. Adv Exp Med Biol. 2010, 678: 147-156. 10.1007/978-1-4419-6306-2_19.
Article
CAS
PubMed
Google Scholar
Janelsins MC, Kohli S, Mohile SG, Usuki K, Ahles TA, Morrow GR: An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol. 2011, 38 (3): 431-438. 10.1053/j.seminoncol.2011.03.014.
Article
PubMed
PubMed Central
Google Scholar
Liu Y, Xiao S, Liu J, Zhou H, Liu Z, Xin Y, Suo WZ: An experimental study of acute radiation-induced cognitive dysfunction in a young rat model. AJNR Am J Neuroradiol. 2010, 31 (2): 383-387. 10.3174/ajnr.A1801.
Article
CAS
PubMed
Google Scholar
Khasraw M, Lassman AB: Neuro-oncology: late neurocognitive decline after radiotherapy for low-grade glioma. Nat Rev Neurol. 2009, 5 (12): 646-647. 10.1038/nrneurol.2009.194.
Article
PubMed
Google Scholar
Gagnon B, Low G, Schreier G: Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study. J Psychiatry Neurosci. 2005, 30 (2): 100-107.
PubMed
PubMed Central
Google Scholar
Joly F, Rigal O, Noal S, Giffard B: Cognitive dysfunction and cancer: which consequences in terms of disease management?. Psychooncology. 2011, 20 (12): 1251-1258. 10.1002/pon.1903.
Article
PubMed
Google Scholar
Kim D: Practical use and risk of modafinil, a novel waking drug. 2012, Toxicology: Environmental Health and, 27-
Google Scholar
Gottesmann C: Function of GABAB and r-containing GABAA receptors (GABAC receptors) in the regulation of basic and higher integrated sleep-waking processes. GABA and sleep: molecular, functional and clinical aspects. Edited by: Monti JM. 2010, Basel: Springer, 169-
Chapter
Google Scholar
Scammell T, Gerashchenko D, Mochizuki T, McCarthy M, Estabrooke I, Sears C, Saper C, Urade Y, Hayaishi O: An adenosine A2a agonist increases sleep and induces Fos in ventrolateral preoptic neurons. Neuroscience. 2001, 107 (4): 653-663. 10.1016/S0306-4522(01)00383-9.
Article
CAS
PubMed
Google Scholar
Engber TM, Koury EJ, Dennis SA, Miller MS, Contreras PC, Bhat RV: Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil. Neuroscience letters. 1998, 241 (2–3): 95-98.
Article
CAS
PubMed
Google Scholar
Kohli S, Fisher SG, Tra Y, Adams MJ, Mapstone ME, Wesnes KA, Roscoe JA, Morrow GR: The effect of modafinil on cognitive function in breast cancer survivors. Cancer. 2009, 115 (12): 2605-2616. 10.1002/cncr.24287.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lundorff L, Jonsson B, Sjogren P: Modafinil for attentional and psychomotor dysfunction in advanced cancer: a double-blind, randomised, cross-over trial. Palliative medicine. 2009, 23 (8): 731-738. 10.1177/0269216309106872.
Article
CAS
PubMed
Google Scholar
Blackhall L, Petroni G, Shu J, Baum L, Farace E: A pilot study evaluating the safety and efficacy of modafinil for cancer-related fatigue. J Palliat Med. 2009, 12 (5): 433-439. 10.1089/jpm.2008.0230.
Article
PubMed
Google Scholar
Volkow N, Fowler J, Wang G, Ding Y, Gatley S: Mechanism of action of methylphenidate: insights from PET imaging studies. J Attention Disord. 2002, 6: S31-
Google Scholar
Wilens TE: Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 2008, 28 (3): S46-
Article
CAS
PubMed
Google Scholar
Lasheen W, Walsh D, Mahmoud F, Davis MP, Rivera N, Khoshknabi DS: Methylphenidate side effects in advanced cancer: a retrospective analysis. American J Hospice and Palliat Med. 2010, 27 (1): 16-23. 10.1177/1049909109345145.
Article
Google Scholar
Mar Fan HG, Clemons M, Xu W, Chemerynsky I, Breunis H, Braganza S, Tannock IF: A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer. Support Care Cancer. 2008, 16 (6): 577-583. 10.1007/s00520-007-0341-9.
Article
PubMed
Google Scholar
Lower EE, Fleishman S, Cooper A, Zeldis J, Faleck H, Yu Z, Manning D: Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial. J Pain and Symptom Management. 2009, 38 (5): 650-662. 10.1016/j.jpainsymman.2009.03.011.
Article
CAS
Google Scholar
Gehring K, Patwardhan SY, Collins R, Groves MD, Etzel CJ, Meyers CA, Wefel JS: A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumour. J Neurooncol. 2012, 107 (1): 165-74. 10.1007/s11060-011-0723-1. doi:10.1007/s11060-011-0723-1. Epub 2011 Oct 2.
Article
CAS
PubMed
Google Scholar
Steinberg M, Lyketsos CG: Pharmacological Therapies in Alzheimer's Disease, in Principles and Practice of Geriatric Psychiatry.Edited by: Abou-Saleh MT, Katona C, Kumar A. 2010, Chichester, UK: John Wiley & Sons, Ltd, doi:10.1002/9780470669600.ch52, 3,
Winocur G, Henkelman M, Wojtowicz JM, Zhang H, Binns MA, Tannock IF: The effects of chemotherapy on cognitive function in a mouse model: a prospective study. Clin Cancer Res. 2012, 18 (11): 3112-3121. 10.1158/1078-0432.CCR-12-0060.
Article
CAS
PubMed
Google Scholar
Winocur G, Binns MA, Tannock I: Donepezil reduces cognitive impairment associated with anti-cancer drugs in a mouse model. Neuropharmacology. 2011, 61 (8): 1222-1228. 10.1016/j.neuropharm.2011.07.013.
Article
CAS
PubMed
Google Scholar
Yazlovitskaya EM, Edwards E, Thotala D, Fu A, Osusky KL, Whetsell WO, Boone B, Shinohara ET, Hallahan DE: Lithium treatment prevents neurocognitive deficit resulting from cranial irradiation. Cancer Res. 2006, 66 (23): 11179-11186. 10.1158/0008-5472.CAN-06-2740.
Article
CAS
PubMed
Google Scholar
Khasraw M, Ashley D, Wheeler G, Berk M: Using lithium as a neuroprotective agent in cancer patients: review. BMC medicine. 2012, Article in press
Google Scholar
Inouye M, Yamamura H, Nakano A: Lithium delays the radiation-induced apoptotic process in external granule cells of mouse cerebellum. J radiat Res. 1995, 36 (3): 203-10.1269/jrr.36.203.
Article
CAS
PubMed
Google Scholar
Cimarosti H, Rodnight R, Tavares A, Paiva R, Valentim L, Rocha E, Salbego C: An investigation of the neuroprotective effect of lithium in organotypic slice cultures of rat hippocampus exposed to oxygen and glucose deprivation. Neuroscience letters. 2001, 315 (1): 33-36.
Article
CAS
PubMed
Google Scholar
Yang ES, Lu B, Hallahan DE: Lithium-mediated neuroprotection during cranial irradiation: a phase 1 trial. ASTRO (american society for therapeutic radiology and oncology) - 49th annual conference. 2007, Los Angeles CA
Google Scholar
Xia F, Yang E, Hallahan D, Lu B: Lithium-mediated neuroprotection during cranial irradiation: a phase I trial. Neuro-oncology. 2008, 10 (5): 887-887.
Google Scholar
Greene-Schloesser D, Robbins ME, Peiffer AM, Shaw EG, Wheeler KT, Chan MD: Radiation-induced brain injury: a review. 2012, Oncology: Frontiers in, 2-
Google Scholar
Robbins ME, Payne V, Tommasi E, Diz DI, Hsu FC, Brown WR, Wheeler KT, Olson J, Zhao W: The AT< sub> 1</sub> receptor antagonist, L-158,809, prevents or ameliorates fractionated whole-brain irradiation–induced cognitive impairment. Int J Radiat Oncol Biol Phys. 2009, 73 (2): 499-505. 10.1016/j.ijrobp.2008.09.058.
Article
CAS
PubMed
Google Scholar
Berbee M, Fu Q, Sree Kumar K, Hauer-Jensen M: Novel strategies to ameliorate radiation injury: a possible role for tetrahydrobiopterin. Current drug targets. 2010, 11 (11): 1366-1374. 10.2174/1389450111009011366.
Article
CAS
PubMed
PubMed Central
Google Scholar
Brown PD, Shook S, Laack NN, Wefel JS, Choucair A, Suh JH, Roberge D, Kavadi V, Mehta MP, Watkins-Bruner D: Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiation therapy (WBRT): first report of RTOG 0614, a placebo-controlled, double-blind, randomized trial. Int J Radiat Oncol Biol Phys. 2012, 84 (3): S1-S2.
Article
Google Scholar
Berk M, Kapczinski F, Andreazza A, Dean O, Giorlando F, Maes M, Yücel M, Gama C, Dodd S, Dean B: Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neuroscience & biobehavioral reviews. 2011, 35 (3): 804-817. 10.1016/j.neubiorev.2010.10.001.
Article
CAS
Google Scholar
Parachikova A, Green KN, Hendrix C, LaFerla FM: Formulation of a medical food cocktail for Alzheimer’s disease: beneficial effects on cognition and neuropathology in a mouse model of the disease. PloS one. 2010, 5 (11): e14015-10.1371/journal.pone.0014015.
Article
PubMed
PubMed Central
Google Scholar
Prakash A, Kumar A: Effect of N-acetyl cysteine against aluminium induced cognitive dysfunction and oxidative damage in rats. Basic & clinical pharmacology & toxicology. 2009, 105 (2): 98-104. 10.1111/j.1742-7843.2009.00404.x.
Article
CAS
Google Scholar
Adair JC, Knoefel JE, Morgan N: Controlled trial of N-acetylcysteine for patients with probable Alzheimer’s disease. Neurology. 2001, 57 (8): 1515-1517. 10.1212/WNL.57.8.1515.
Article
CAS
PubMed
Google Scholar
Lindsay J, Laurin D, Verreault R, Hubert R, Helliwell B, Hill GB, McDowell I: Risk factors for Alzheimer’s disease: a prospective analysis from the Canadian study of health and aging. Am J Epidemiol. 2002, 156 (5): 445-453. 10.1093/aje/kwf074.
Article
PubMed
Google Scholar
Tiwari V, Chopra K: Resveratrol prevents alcohol induced cognitive deficits and brain damage by blocking inflammatory signaling and cell death cascade in neonatal rat brain. J Neurochem. 2011, 117 (4): 678-690.
CAS
PubMed
Google Scholar
Howes MJR, Perry E: The role of phytochemicals in the treatment and prevention of dementia. Drugs Aging. 2011, 28 (6): 439-468. 10.2165/11591310-000000000-00000.
Article
CAS
PubMed
Google Scholar
Kim J, Lee HJ, Lee KW: Naturally occurring phytochemicals for the prevention of Alzheimer’s disease. J Neurochem. 2010, 112 (6): 1415-1430. 10.1111/j.1471-4159.2009.06562.x.
Article
CAS
PubMed
Google Scholar
Reid CM, Storey E, Wong TY, Woods R, Tonkin A, Wang JJ, Kam A, Janke A, Essex R, Abhayaratna WP: Aspirin for the prevention of cognitive decline in the elderly: rationale and design of a neuro-vascular imaging study (ENVIS-ion). BMC neurology. 2012, 12 (1): 3-10.1186/1471-2377-12-3.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cunningham C, Skelly D: Non-steroidal anti-inflammatory drugs and cognitive function: are prostaglandins at the heart of cognitive impairment in dementia and delirium?. J Neuroimmune Pharmacol. 2012, 7 (1): 60-73. 10.1007/s11481-011-9312-5.
Article
PubMed
Google Scholar
Leoutsakos JM, Muthen BO, Breitner JC, Lyketsos CG, ADAPT Research Team: Effects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's Disease Anti-inflammatory Prevention Trial. Int J Geriatr Psychiatry. 2012, 27 (4): 364-374. doi: 10.1002/gps.2723. Epub 2011 May 10
PubMed
Google Scholar
Jacobs EJ, Newton CC, Gapstur SM, Thun MJ: Daily aspirin use and cancer mortality in a large US cohort. J Natl Cancer Inst. 2012, 104 (16): 1208-1217. 10.1093/jnci/djs318.
Article
CAS
PubMed
Google Scholar
Kang JH, Cook N, Manson JA, Buring JE, Grodstein F: Low dose aspirin and cognitive function in the women’s health study cognitive cohort. BMJ. 2007, 334 (7601): 987-10.1136/bmj.39166.597836.BE.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jaturapatporn D, Isaac MGEKN, McCleery J, Tabet N: Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer’s disease. 2012, Library: The Cochrane
Google Scholar